来源：新浪证券-红岸工作室 12月15日，金凯生科跌0.54%，成交额3034.71万元，换手率1.61%，总市值39.96亿元。 异动分析 CRO概念+减肥药+阿尔茨海默概念+氟化工概念+人民币贬值受益 1、公司的主营业务是为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定 制研发生产服务。公司的主要产品是含氟类CDMO业务、非含氟类CDMO业务。 2、2023年8月8日互动易回复：公司上市的募投项目"医药中间体项目"和"年产 190 吨高端医药产品项目 包含司美格鲁肽（Semaglutide）口服制剂小分子吸收增强剂 SNAC 的中间体。 3、2023年9月21日互动易回复：公司为欧美生物创新药公司提供阿尔茨海默相关中间体服务。 4、2025年7月9日互动易，公司现有氟化生产能力包括特殊氟化剂氟化（如四氟化硫、氟化氢吡啶、氟 化氢三乙胺）、氟化氢氟化、氟化钾氟化等。 5、根据2024年年报，公司海外营收占比为61.18%，受益于人民币贬值。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 今日主力净流入86.12万，占比0.03%，行业排名1 ...

来源：新浪证券-红岸工作室 12月15日，华利集团跌2.01%，成交额1.95亿元，换手率0.28%，总市值683.98亿元。 异动分析 三胎概念+体育产业+人民币贬值受益 区间今日近3日近5日近10日近20日主力净流入1442.24万1089.21万23.92万-2441.15万-5654.25万 主力持仓 主力没有控盘，筹码分布非常分散，主力成交额4304.24万，占总成交额的6.19%。 技术面：筹码平均交易成本为57.04元 1、公司从事运动鞋履的开发设计、生产与销售，是全球领先的运动鞋专业制造商，公司服务的品牌， 很多都有儿童系列，包括幼童系列。公司开发、制造面向幼童的运动鞋。 2、华利股份从事运动鞋履的开发设计、生产与销售，是全球领先的运动鞋专业制造商，主要为Nike、 Converse、Vans、Puma、UGG、Columbia、Under Armour、HOKA ONE ONE等全球知名运动品牌提供 开发设计与制造服务。 3、根据2024年年报，公司海外营收占比为99.80%，受益于人民币贬值。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 今日 ...

Core Viewpoint - The company Zhongyin Fashion has shown a significant increase in stock price and market activity, with a focus on its business operations in the footwear industry and emerging technologies like virtual digital humans and AI. Group 1: Company Performance - On December 15, Zhongyin Fashion's stock rose by 3.53%, with a trading volume of 63.81 million yuan and a market capitalization of 3.802 billion yuan [1] - The company reported a revenue of 264 million yuan for the period from January to September 2025, reflecting a year-on-year decrease of 8.48%, while the net profit attributable to shareholders was -12.32 million yuan, indicating a significant increase of 50.10% year-on-year [7][8] - The company's main business revenue composition includes 77.12% from supply chain integration, 6.93% from footwear production, 6.61% from design services, 4.59% from brand operations, and 1.46% from cultural tourism services [7] Group 2: Industry and Market Trends - The company established a footwear production base in Xinjiang in response to national policies supporting the development of the western region, which aligns with the "three-child policy" and benefits from the depreciation of the RMB [2] - As of the 2024 annual report, overseas revenue accounted for 83.07% of total revenue, benefiting from the depreciation of the RMB [3] - The company is involved in advanced technologies related to virtual digital humans, with its subsidiary, Xinchangyuan Technology, developing products that support multi-modal content generation [3]

来源：新浪证券-红岸工作室 12月15日，兆龙互连跌5.19%，成交额4.51亿元，换手率3.31%，总市值164.42亿元。 异动分析 铜缆高速连接+光纤概念+5G+机器视觉+人民币贬值受益 1、根据2025年7月30日互动易：公司凭借在高速电缆领域的技术积累，已成为国际头部互联方案商在有 源电缆（AEC）领域的核心合作伙伴。 2、根据2025年5月29日投资者关系活动记录表：公司光产品涵盖光纤跳线、MPO/MTP预端接、LC光纤 连接器等。目前国内主要服务于金融系统（如银行）、高等院校、医疗、展馆等中高端项目；同时正进 一步拓展海外市场，逐步形成小批量业务阶段。 3、招股说明披露：公司是国内少数有能力设计制造超六类、七类、超七类乃至八类数据电缆的企业， 能够满足 5G 时代新的数据传输需求。 4、2025年2月27日互动易：公司机器视觉产品已经批量运用于多种机器视觉连接系统解决方案，包含 CoaXPress、GigE、10GigE、Camera Link、光跳线等。 5、根据2024年年报，公司海外营收占比为61.93%，受益于人民币贬值。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不 ...

12月15日，海泰新光涨1.35%，成交额5588.48万元，换手率1.04%，总市值53.81亿元。 异动分析 来源：新浪证券-红岸工作室 医疗器械概念+人民币贬值受益+专精特新 1、公司始终致力于将光学技术与医疗器械行业的前沿应用趋势相结合，研究发展高性能的尖端内窥镜 器械产品。目前，公司是国内少有的具备从核心部件、关键设备到系统集成的行业垂直整合能力的企 业。 2、根据2024年年报，公司海外营收占比为69.12%，受益于人民币贬值。 3、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部专精特新 小巨人企业名单。 公司简介 资料显示，青岛海泰新光科技股份有限公司位于山东省青岛市崂山区科苑纬四路100号，成立日期2003 年6月11日，上市日期2021年2月26日，公司主营业务涉及医用内窥镜器械和光学产品的研发、生产和销 售。主营业务收入构成为：医用内窥镜器械64.86%，光学产品21.63% ...

Core Viewpoint - The company, Haiprui, is a leading multinational pharmaceutical enterprise established in 1998, focusing on the heparin industry chain, biopharmaceutical CDMO, and innovative drug investment, development, and commercialization, aiming to provide high-quality and effective medications and services globally [2][3]. Group 1: Company Overview - Haiprui's main business segments include heparin raw materials, downstream low molecular weight heparin products, and CDMO services, with revenue contributions of 63.06% from formulations, 18.59% from CDMO, and 16.05% from heparin raw materials [7]. - As of September 30, 2025, Haiprui reported a revenue of 4.194 billion yuan, a year-on-year increase of 3.09%, while the net profit attributable to shareholders decreased by 29.04% to 554 million yuan [7]. - The company has a total market capitalization of 17.123 billion yuan, with a trading volume of 33.7636 million yuan and a turnover rate of 0.23% on December 15 [1]. Group 2: Financial Performance - The overseas revenue contribution for Haiprui is 93.04%, benefiting from the depreciation of the Renminbi [3]. - The company has distributed a total of 4.21 billion yuan in dividends since its A-share listing, with 514 million yuan distributed over the past three years [8]. Group 3: Market Position and Trends - Haiprui operates in the pharmaceutical and biotechnology sector, specifically in chemical pharmaceuticals and formulations, and is involved in various concept sectors including biopharmaceuticals, raw materials, vaccines, and innovative drugs [7]. - The stock has shown a net inflow of 605,300 yuan from major investors, indicating a lack of clear trend in major holdings, with the stock's average trading cost at 11.59 yuan [5][6].

来源：新浪证券-红岸工作室 12月12日，致欧科技跌0.21%，成交额2550.98万元，换手率0.69%，总市值76.43亿元。 异动分析 露营经济+网红经济+跨境电商+人民币贬值受益+宠物经济 1、2023年6月1日招股书显示公司庭院系列产品分为庭院家居类、休闲类和运动类。其中,庭院家居类主 要包括藤编家具套装、篱笆、花园桌、太阳伞等产品;休闲类主要包括吊床、吊椅、野餐垫、睡袋、休 闲椅、行军床、秋千等产品。 2、根据2023年11月23日互动易显示，公司根据产品使用场景和网红粉丝画像进行选择合作红人，公司 已与@paula_silvagni_interiors（INS 56万粉丝）、@maria_nordichouse（INS 50万粉丝）等网红达人开展 过合作。公司已与网红达人合作在美国Tik Tok直播带货，目前贡献的销售额较小 3、2023年6月9日互动易：公司经过多年持续对仓储物流体系的建设，已建立了具有差异化竞争优势的 "国内外自营仓+平台仓+第三方合作仓"跨境电商出口仓储物流体系。目前，公司在德国、美国等地设 立了多个海外自营仓，可以实现仓储物流自主管控，提高了发货、退换货、售后服务等业务环 ...

Core Viewpoint - The company, Shantou Ultrasonic Instrument Research Institute Co., Ltd., specializes in the research, development, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with a significant portion of its revenue coming from overseas due to the depreciation of the RMB [3][4]. Company Overview - Shantou Ultrasonic Instrument Research Institute Co., Ltd. was established on November 15, 1982, and went public on January 22, 2025. It is recognized as a national key high-tech enterprise [7]. - The company's main business segments include medical ultrasound (71.16% of revenue), industrial ultrasound (17.30%), accessories (5.72%), X-ray (4.56%), and other (1.26%) [7]. Financial Performance - For the period from January to September 2025, the company reported a revenue of 254 million yuan, a year-on-year decrease of 2.90%, and a net profit attributable to shareholders of 88.94 million yuan, down 3.66% year-on-year [8][9]. - As of September 30, 2025, the company's overseas revenue accounted for 55.26% of total revenue, benefiting from the depreciation of the RMB [3]. Market Activity - On December 12, the company's stock price increased by 1.09%, with a trading volume of 22.8866 million yuan and a turnover rate of 1.76%, bringing the total market capitalization to 9.552 billion yuan [1]. - The stock has experienced a net outflow of 1.2743 million yuan from major investors today, indicating a lack of strong control by major shareholders, with a very dispersed distribution of shares [5][6]. Recent Developments - The company participated in the 97th WVC Annual Meeting from March 3 to 5, 2025, showcasing its innovative veterinary medical imaging achievements and engaging with industry experts [2].

Core Viewpoint - The company, Ningbo Jialian Technology Co., Ltd., is a leading manufacturer in the global plastic dining utensils industry, with a significant focus on overseas sales and a growing presence in cross-border e-commerce [2][3]. Group 1: Company Overview - Ningbo Jialian Technology specializes in the research, production, and sales of plastic products, biodegradable products, and plant fiber products, with plastic products accounting for 84.41% of its revenue [7]. - The company was established on August 7, 2009, and went public on December 9, 2021 [7]. - As of September 30, 2025, the company reported a revenue of 1.865 billion yuan, representing a year-on-year growth of 8.25%, while the net profit attributable to shareholders was -73.8145 million yuan, a decrease of 209.95% [8]. Group 2: Market Position and Financials - The company’s overseas revenue accounted for 55.43% of total revenue, benefiting from the depreciation of the RMB [3]. - In 2021, the company’s export sales accounted for 70.47% of its total sales, primarily targeting developed regions such as North America, Europe, and Oceania [2]. - The company has diversified its production capabilities with a factory in Thailand, which includes production lines for 3D printing materials, plastic dining utensils, and plant fiber products [3]. Group 3: Product and Technology Focus - The company is focusing on the research and application of PLA materials and has made early investments in the consumer-grade FDM materials and products sector [2]. - The 3D printing materials produced by the company have broad application prospects across various fields, including industrial design, education, toys, and medical sectors [2].

Core Viewpoint - The company, Zhejiang Biyi Electric Co., Ltd., specializes in the design, manufacturing, and sales of small household appliances, with a significant focus on smart home technology and artificial intelligence integration. Group 1: Company Overview - The company was established on March 20, 2001, and went public on February 18, 2022. Its main business includes kitchen appliances, with revenue composition as follows: air fryers and air ovens 85.12%, coffee machines and others 9.43%, deep fryers 4.43%, and environmental appliances 1.03% [8] - As of October 31, the number of shareholders is 16,600, a decrease of 4.28% from the previous period, while the average circulating shares per person increased by 4.47% [8] Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 1.756 billion yuan, representing a year-on-year growth of 18.66%. However, the net profit attributable to the parent company was 72.204 million yuan, a decrease of 29.00% year-on-year [8] - The company has distributed a total of 266 million yuan in dividends since its A-share listing, with 215 million yuan distributed over the past three years [9] Group 3: Market Position and Trends - The company has a strong international presence, with overseas revenue accounting for 92.25%, benefiting from the depreciation of the Chinese yuan [4] - The company is expanding into the smart robotics sector, currently focusing on smart vacuum cleaners and washing machines [3][4] - The company has initiated the development of its own AI smart platform to enhance user experience through features like smart voice, visual control, remote control, and product simulation [2][4] Group 4: Technical Analysis - The average trading cost of the stock is 21.10 yuan, with the current stock price near a resistance level of 20.41 yuan, indicating potential for a price correction if this level is not surpassed [7]